Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults

Journal of Psychiatric Research

Volumn 48, Issue 1, 2014, Pages 13-15

  Magalhaes, Pedro V S ^a   Jansen, Karen ^b   Stertz, Laura ^a   Ferrari, Pamela ^a   Pinheiro, Ricardo Tavares ^b   da Silva, Ricardo A ^b   Kapczinski, Flávio ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Bipolar disorder; CCL11; Eotaxin 11; Major depression; Population based

Indexed keywords

CHEMOKINE RECEPTOR CCR3; EOTAXIN;

BIPOLAR DISORDER; CELL PROLIFERATION; COGNITION; DRUG MISUSE; EOSINOPHIL; GLIA; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; LETTER; MAJOR DEPRESSION; MOOD DISORDER; NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOCIAL CLASS; YOUNG MANIA RATING SCALE;

BIPOLAR DISORDER; CCL11; EOTAXIN-11; MAJOR DEPRESSION; POPULATION-BASED;

BRAZIL; CHEMOKINE CCL11; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; MALE; MOOD DISORDERS; MULTIVARIATE ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 84888437390     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.10.007     Document Type: Letter

References (18)

1. ABEP. Online at www.abep.org; 2008 [accessed 20.06.13].
2. Barbosa I.G., Rocha N.P., Bauer M.E., de Miranda A.S., Huguet R.B., Reis H.J., et al. Chemokines in bipolar disorder: trait or state?. European Archives of Psychiatry and Clinical Neuroscience 2013, 263:159-165.
3. Brietzke E., Kauer-Sant'Anna M., Teixeira A.L., Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain Behavior and Immunity 2009, 23:1079-1082.
4. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. Journal of Experimental Medicine 2010, 207:1067-1080.
5. Fleck M.P.A., Poirierlittre M.F., Guelfi J.D., Bourdel M.C., Loo H. Factorial structure of the 17-item Hamilton depression rating-scale. Acta Psychiatrica Scandinavica 1995, 92:168-172.
6. Grassi-Oliveira R., Brieztke E., Teixeira A., Pezzi J.C., Zanini M., Lopes R.P., et al. Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Revista Brasileira de Psiquiatria 2012, 34:71-75.
7. Jansen K., Magalhaes P.V., Tavares Pinheiro R., Kapczinski F., Silva R.A. Early functional impairment in bipolar youth: a nested population-based case-control study. Journal of Affective Disorders 2012, 142:208-212.
8. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V.S., Kauer-Sant'Anna M., Klamt F., et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Molecular Psychiatry 2010, 15:784-786.
9. Krathwohl M.D., Kaiser J.L. Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 2004, 22:109-118.
10. Magalhaes P.V.S., Jansen K., Pinheiro R.T., Colpo G.D., da Motta L.L., Klamt F., et al. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. International Journal of Neuropsychopharmacology 2012, 15:1043-1050.
11. Magalhaes P.V.S., Jansen K., Pinheiro R.T., Klamt F., Teixeira A.L., da Silva R.A., et al. Systemic toxicity in early-stage mood disorders. Journal of Psychiatric Research 2011, 45:1407-1409.
12. Mendelsohn A.R., Larrick J.W. Overcoming the aging systemic milieu to restore neural stem cell function. Rejuvenation Research 2011, 14:681-684.
13. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry 2013, 18:595-606.
14. Simon N.M., McNamara K., Chow C.W., Maser R.S., Papakostas G.I., Pollack M.H., et al. A detailed examination of cytokine abnormalities in major depressive disorder. European Neuropsychopharmacology 2008, 18:230-233.
15. Van Coillie E., Van Damme J., Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine & Growth Factor Reviews England 1999, 61-86.
16. Vilela J.A.A., Crippa J.A.S., Del-Ben C.M., Loureiro S.R. Reliability and validity of a Portuguese version of the Young Mania Rating Scale. Brazilian Journal of Medical and Biological Research 2005, 38:1429-1439.
17. Villeda S.A., Luo J., Mosher K.I., Zou B., Britschgi M., Bieri G., et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011, 477:90-94.
18. Villeda S.A., Wyss-Coray T. The circulatory systemic environment as a modulator of neurogenesis and brain aging. Autoimmunity Reviews 2013, 12:674-677.